Skip to Main Content

Paper Details

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Cancer Discov
110
2021
Cancer, Patients, RNA, Rare Cancers, Rare cancers, cancers, patient, patients, rare cancers, tumor
Author NameAffiliation
Peter HorakNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Peter Horak
Simon KreutzfeldtNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Simon Kreutzfeldt
Barbara Hutter
Barbara Hutter
Barbara Hutter
Barbara Hutter
Sebastian Uhrig
Sebastian Uhrig
Michael Allg??uerInstitute of Pathology, Heidelberg University Hospital
Leo Ruhnke
Leo RuhnkeCenter for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden
Leo Ruhnke
Volker EndrisInstitute of Pathology, Heidelberg University Hospital
Olaf NeumannInstitute of Pathology, Heidelberg University Hospital
Stephan Wolf
Stephan Wolf
Ivo Buchhalter
Ivo Buchhalter
Peter Schirmacher
Peter SchirmacherInstitute of Pathology, Heidelberg University Hospital
Frederick Klauschen
Frederick KlauschenInstitute of Pathology, Charite - Universitatsmedizin Berlin, and Berlin Institute of Health
Nikolas von BubnoffUniversity of Freiburg Medical Center, University of Freiburg
Nikolas von BubnoffUniversity Hospital of Schleswig-Holstein
Christof von KalleClinical Study Center, Charite - Universitatsmedizin Berlin, and Berlin Institute of Health
Benedikt Brors
Benedikt Brors
Benedikt Brors
Benedikt Brors
Albrecht Stenzinger
Albrecht StenzingerInstitute of Pathology, Heidelberg University Hospital
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Stefan Fr??hling
  • 1 - 35

Datasets